Skip to main content
. Author manuscript; available in PMC: 2014 Sep 9.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528. doi: 10.1002/14651858.CD006528.pub2

Analysis 2.31. Comparison 2 Mirtazapine versus SSRIs, Outcome 31 Secondary outcome (SKEWED DATA: depression severity) at 2 weeks.

Secondary outcome (SKEWED DATA: depression severity) at 2 weeks

Study Comparator drug Measurement Mirtazapine: mean SD N Comparator: mean SD N note
Schoemaker 2002 Fluvoxamine HAMD-17 −9.2 5.86 199 −7.3 6.11 203
Winokur 2003 Fluoxetine HAMD-21 16.1 5.7 8 18.0 9.6 11